226 related articles for article (PubMed ID: 18221926)
1. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia.
Lynch AM; Murphy JR; Byers T; Gibbs RS; Neville MC; Giclas PC; Salmon JE; Holers VM
Am J Obstet Gynecol; 2008 Apr; 198(4):385.e1-9. PubMed ID: 18221926
[TBL] [Abstract][Full Text] [Related]
2. Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia.
Lynch AM; Eckel RH; Murphy JR; Gibbs RS; West NA; Giclas PC; Salmon JE; Holers VM
Am J Obstet Gynecol; 2012 May; 206(5):428.e1-8. PubMed ID: 22542119
[TBL] [Abstract][Full Text] [Related]
3. The Relationship of Longitudinal Levels of Complement Bb During Pregnancy with Preeclampsia.
Lynch AM; Wagner BD; Giclas PC; West NA; Gibbs RS; Holers VM
Am J Reprod Immunol; 2016 Feb; 75(2):104-11. PubMed ID: 26510395
[TBL] [Abstract][Full Text] [Related]
4. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
[TBL] [Abstract][Full Text] [Related]
5. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth.
Lynch AM; Gibbs RS; Murphy JR; Byers T; Neville MC; Giclas PC; Salmon JE; Van Hecke TM; Holers VM
Am J Obstet Gynecol; 2008 Oct; 199(4):354.e1-8. PubMed ID: 18928972
[TBL] [Abstract][Full Text] [Related]
6. Maternal and fetal alternative complement pathway activation in early severe preeclampsia.
Hoffman MC; Rumer KK; Kramer A; Lynch AM; Winn VD
Am J Reprod Immunol; 2014 Jan; 71(1):55-60. PubMed ID: 24128411
[TBL] [Abstract][Full Text] [Related]
7. Altered Maternal Plasma Glycogen Phosphorylase Isoenzyme BB as a Biomarker for Preeclampsia and Small for Gestational Age.
McCarthy FP; Doyle A; Khashan AS; Kenny LC
Reprod Sci; 2016 Jun; 23(6):738-47. PubMed ID: 26614266
[TBL] [Abstract][Full Text] [Related]
8. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
Kim MY; Guerra MM; Kaplowitz E; Laskin CA; Petri M; Branch DW; Lockshin MD; Sammaritano LR; Merrill JT; Porter TF; Sawitzke A; Lynch AM; Buyon JP; Salmon JE
Ann Rheum Dis; 2018 Apr; 77(4):549-555. PubMed ID: 29371202
[TBL] [Abstract][Full Text] [Related]
9. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
[TBL] [Abstract][Full Text] [Related]
10. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
Poon LC; Wright D; Rolnik DL; Syngelaki A; Delgado JL; Tsokaki T; Leipold G; Akolekar R; Shearing S; De Stefani L; Jani JC; Plasencia W; Evangelinakis N; Gonzalez-Vanegas O; Persico N; Nicolaides KH
Am J Obstet Gynecol; 2017 Nov; 217(5):585.e1-585.e5. PubMed ID: 28784417
[TBL] [Abstract][Full Text] [Related]
11. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
[TBL] [Abstract][Full Text] [Related]
12. Retinol-Binding Protein 4 and Lipids Prospectively Measured During Early to Mid-Pregnancy in Relation to Preeclampsia and Preterm Birth Risk.
Mendola P; Ghassabian A; Mills JL; Zhang C; Tsai MY; Liu A; Yeung EH
Am J Hypertens; 2017 Jun; 30(6):569-576. PubMed ID: 28338737
[TBL] [Abstract][Full Text] [Related]
13. Complement factor B activation in patients with preeclampsia.
Velickovic I; Dalloul M; Wong KA; Bakare O; Schweis F; Garala M; Alam A; Medranda G; Lekovic J; Shuaib W; Tedjasukmana A; Little P; Hanono D; Wijetilaka R; Weedon J; Lin J; Toledano Rd; Zhang M
J Reprod Immunol; 2015 Jun; 109():94-100. PubMed ID: 25604034
[TBL] [Abstract][Full Text] [Related]
14. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia.
Sorensen TK; Malinow MR; Williams MA; King IB; Luthy DA
Gynecol Obstet Invest; 1999; 48(2):98-103. PubMed ID: 10460999
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
[TBL] [Abstract][Full Text] [Related]
16. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.
Espinoza J; Romero R; Nien JK; Gomez R; Kusanovic JP; Gonçalves LF; Medina L; Edwin S; Hassan S; Carstens M; Gonzalez R
Am J Obstet Gynecol; 2007 Apr; 196(4):326.e1-13. PubMed ID: 17403407
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
[TBL] [Abstract][Full Text] [Related]
18. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension.
Greenberg VR; Silasi M; Lundsberg LS; Culhane JF; Reddy UM; Partridge C; Lipkind HS
Am J Obstet Gynecol; 2021 May; 224(5):521.e1-521.e11. PubMed ID: 33157064
[TBL] [Abstract][Full Text] [Related]
19. Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.
Barton JR; Woelkers DA; Newman RB; Combs CA; How HY; Boggess KA; Martin JN; Kupfer K; Sibai BM;
Am J Obstet Gynecol; 2020 Mar; 222(3):259.e1-259.e11. PubMed ID: 31518550
[TBL] [Abstract][Full Text] [Related]
20. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group.
Joffe GM; Esterlitz JR; Levine RJ; Clemens JD; Ewell MG; Sibai BM; Catalano PM
Am J Obstet Gynecol; 1998 Oct; 179(4):1032-7. PubMed ID: 9790393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
